Richard D. Truesdell, Jr.
Lawyers
Filters
Prime Medicine $161 million stock and pre-funded warrants offering
The common stock is listed on the Nasdaq Global Market
Marsh McLennan $1 billion senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
Cigna $4.5 billion senior notes offering
The senior notes are due 2029, 2031, 2034 and 2054
Metagenomi $93.75 million IPO
The shares are listed on the Nasdaq Global Market
Immunocore Holdings $402.5 million convertible notes offering
The 2.5% convertible notes are due 2030
Spirit AeroSystems $460 million stock and exchangeable notes offering
The stock is listed on the New York Stock Exchange
Bristol Myers Squibb $4.5 billion notes offering
The investment-grade offering comprised four tranches
Arm $4.87 billion IPO
The deal is the largest U.S. IPO since November 2021
Marsh McLennan $1.6 billion senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
Banc of California merger with PacWest and $400 million equity raise
We are advising JPMorgan as financial adviser and placement agent to Banc of California